COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,281 Articles (22,759 medRxiv, 8,522 bioRxiv)

Most recent first Previous |  Page 2407: Articles 24061-24070  | Next

Quantification of the association between predisposing health conditions, demographic, and behavioural factors with hospitalisation, intensive care unit admission, and death from COVID-19: a systematic review and meta-analysis
Fernandez Villalobos, N. V., Ott, J. J., Klett-Tammen, C. J., Bockey, A., Vanella, P., Krause, G., Lange, B.
10.1101/2020.07.30.20165050 — Posted: 2020-08-01
Self-rated smell ability enables highly specific predictors of COVID-19 status: a case control study in Israel
Karni, N., Klein, H., Asseo, K., Benjamini, Y., Israel, S., Nimri, M., Olstein, K., Nir-Paz, R., Hershko, A., Muszkat, M., Niv, M. Y.
10.1101/2020.07.30.20164327 — Posted: 2020-08-01
Sustained Cellular Immune Dysregulation in Individuals Recovering from SARS-CoV-2 Infection
Files, J. K., Boppana, S., Perez, M. D., Sarkar, S., Lowman, K. E., Qin, K., Sterrett, S., Carlin, E., Bansal, A., Sabbaj, S., Long, D. M., Kutsch, O., Kobie, J., Goepfert, P. A., Erdmann, N.
10.1101/2020.07.30.20165175 — Posted: 2020-08-01 Discussion: Onsite | Offsite
High rate of major drug-drug interactions of lopinavir-ritonavir for COVID-19 treatment
Macias, J., Pinilla, A., Lao-Dominguez, F. A., Corma, A., Contreras-Macias, E., Gonzalez-Serna, A., Gutierrez-Pizarraya, A., Fernandez-Fuertes, M., Morillo-Verdugo, R., Trigo, M., Real, L. M., Pineda, J. A.
10.1101/2020.07.30.20165027 — Posted: 2020-08-01
Comparative effects of viral transport medium heat inactivation upon downstream SARS-CoV-2 detection in patient samples
Thompson, J. L., Velasco, A. D. R., Cardall, A., Tarbox, R., Richardson, J., Clarke, G., Lister, M., Howson-Wells, H. C., Fleming, V. M., Khakh, M., Sloan, T., Duckworth, N., Denning, C., McClure, C. P., Benest, A. V., Seedhouse, C. H.
10.1101/2020.07.30.20164988 — Posted: 2020-08-01
Improving COVID-19 critical care mortality over time in England: A national cohort study, March to June 2020
Dennis, J., McGovern, A., Vollmer, S., Mateen, B. A.
10.1101/2020.07.30.20165134 — Posted: 2020-08-01 Discussion: Onsite
Estrogen and COVID-19 symptoms: associations in women from the COVID Symptom Study
Costerira, R., Lee, K. A., Murray, B., Christiansen, C., Castillo-Fernandez, J., Ni Lochlainn, M., Capdevila Pujol, J., Buchan, I., Kenny, L. C., Wolf, J., Ourselin, S., Steves, C., Spector, T., Newson, L., Bell, J.
10.1101/2020.07.30.20164921 — Posted: 2020-08-01 Discussion: Onsite
High SARS-CoV-2 seroprevalence in Health Care Workers but relatively low numbers of deaths in urban Malawi
Chibwana, M. G., Jere, K. C., kamng'ona, R., Mandolo, J., Katunga-Phiri, V., Tembo, D., Mitole, N., Musasa, S., Sichone, S., Lakudzala, A., Sibale, L., Matambo, P., Kadwala, I., Byrne, R. L., Mbewe, A., Morton, B., Phiri, C., Mallewa, J., Mwandumba, H. C., Adams, E. R., Gordon, S. B., Jambo, K. C.
10.1101/2020.07.30.20164970 — Posted: 2020-08-01
Hybrid capture-based sequencing enables unbiased recovery of SAR-CoV-2 genomes from fecal samples and characterization of the dynamics of intra-host variants
Li, M., Xu, Y., Kang, L., Shen, Z., Li, X., Wu, W., Ma, W., Fang, C., Yang, F., Jiang, X., Gong, S., Zhang, L.
10.1101/2020.07.30.230102 — Posted: 2020-08-01
Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy
Barone, S. M., Paul, A. G. A., Muehling, L. M., Lannigan, J. A., Kwok, W. W., Turner, R. B., Woodfolk, J. A., Irish, J. M.
10.1101/2020.07.31.190454 — Posted: 2020-08-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).